Partner Content Partner Content Highly Potent Active Pharmaceutical Ingredients - Under 2 We... HPAPI 2018
Partner Content Partner Content SMi’s HPAPI 2018 Conference: Exclusive Interview Released wi... HPAPI 2018
Partner Content Partner Content Introducing the 2nd Annual HPAPI Conference this May 2018 2nd Annual HPAPI Conference this May 2018
News Gilead's twice-yearly PrEP drug is cleared by FDA Gilead has FDA approval for a twice-yearly PrEP drug, but could proposed cuts to US funding for HIV prevention programmes hinder its take-up?
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
